EC 500-038-2
Also known as poly(ethylene oxide), PEG, and PEO.
chemXplore tracks 4 projects producing polyethylene glycol, of which one is active.
Of the active ones, 1 new construction.
Premium, highly purified excipients for demanding parenteral applications and a new U.S. PEG manufacturing site to strengthen North and Latin American supply chains.
First complement inhibitor in Japan for patients aged 12+ with these rare kidney diseases; VALIANT showed 68.1% proteinuria reduction and eGFR stabilization versus placebo.
Evaluating up to 50% stake in Zhoushan advanced-materials project; PDA sets framework toward a potential FID and joint development.
GMP-compliant excipient production strengthens supply-chain resilience, shortens lead times, and improves continuity and traceability for pharma customers across North & Latin America.
Natrineo CR8, a natural emulsifier, enhances skin hydration and sun care. It's 92% natural, biodegradable, and supports sustainable palm oil, aligning with modern beauty values.
The project will create up to 200 jobs, invest 500 million euros, and include a CO2 recovery system. It aims to produce 180,000 tons of ethylene oxide annually, with construction starting in 2021.
A subscription lists every plant we track for polyethylene glycol, with its owners and capacity. What a subscription does →
